Recro Signs Development and Manufacturing Deal with U.S. Government
The contract involves supporting the clinical development of a topical dermal treatment for the prevention of skin cancer.
January 26, 2022
by contractpharma
Recro eyes expansion to full-service CDMO status
The solid oral dose specialist signs letter of intent for acquisition of a CDMO providing a full range of services
August 12, 2021
by cphi-online
Recro Pharma Appoints Erica Raether as VP of People, Culture and ESG
Raether has 20 years of human resources experience within the biotech and medical device industries.
July 23, 2021
by contractpharma
Recro Pharma Inks Development and Mfg. Pact
To support a client’s ongoing clinical development of an orally administered, minimally-absorbed investigational compound.
July 14, 2021
by contractpharma
Recro Expands Board of Directors
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving formulation and manufacturing challenges for companies developing oral solid dose drug products, has appointed Laura L. Parks, Ph.D., to the company’s ...
June 17, 2021
by contractpharma
RECRO Expands Capabilities for Clinical Trial Services
Recro Pharma, Inc. has expanded clinical capabilities for its growing Clinical Trial Services offerings to include clinical-scale sachet and blister packaging for clinical trial pharmaceuticals.
June 3, 2021
by contractpharma
Recro Pharma, Astex Enter Drug Development Alliance
Recro Pharma, Inc., a CDMO providing services for complex formulation and manufacturing challenges for oral solid dose drug products, has signed a new development agreement with Astex Pharmaceuticals, Inc.
May 19, 2021
by contractpharma
Recro, Ensysce Expand Development and Manufacturing Partnership
Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, has signed additional agreements with an existing ...
April 16, 2021
by contractpharma
Recro Pharma Expands Business Development Team
Recro Pharma Inc. has strengthened the company’s business development team to support its strategic objective of expanding and diversifying its customer base.
April 6, 2021
by contractpharma
Recro, Teva Extend License and Supply Agreement
Recro Gainesville, the contract development and manufacturing organization (CDMO) division of Recro Pharma, has amended its existing license and supply agreement with ...
April 18, 2019
by contractpharma
Recro Pharma expands CDMO business in Georgia
Recro Pharma was granted a March 2019 PDUFA date for its non-opioid pain drug after providing the FDA with additional data and answering manufacturing questions raised in a complete response letter.
November 8, 2018
by fiercepharma
Recro Gainesville Adds New Facility
Recro Gainesville Adds New Facility
November 7, 2018
by contractpharma